Stock listing
HKEX:2257 Sirnaomics Ltd. (聖諾醫藥) 股價
Home listing (HKEX) of Sirnaomics Ltd.
Follow Sirnaomics Ltd. into a list and get an email when it puts out news.
Share price · HKEX:2257
$3.60 HKD -0.54 (-13.1%)
Close on Nov 20, 2026
- Day range
- $3.60 – $4.08 HKDNov 20, 2026
- Volume
- 43,700 sharesNov 20, 2026
- Market cap
- $400.8M HKDAt the close on Nov 20, 2026 · price × 111.3M shares outstanding
- 52-week range
- $3.55 – $10.72 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $193,780 HKDMedian day 21,550 shares · 2 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:2257 · Home | $3.60 HKD | -0.545 (-13.1%) | 43,700 | $3.90 | $4.075 | $3.60 | $4.145 | Close on Nov 20, 2026 |
| Frankfurt:V5Z | €0.398 EUR | -0.038 (-8.7%) | — | €0.404 | €0.404 | €0.398 | €0.436 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2257 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $3.60 | -0.545 | -13.1% | $3.90 | $4.075 | $3.60 | 43,700 | |
| $4.145 | -0.035 | -0.8% | $4.18 | $4.18 | $4.145 | 50 | |
| $4.18 | 0.00 | 0.0% | $4.18 | $4.18 | $4.18 | 50 | |
| $4.18 | +0.125 | +3.1% | $3.93 | $4.20 | $3.82 | 634,967 | |
| $4.055 | +0.01 | +0.2% | $3.96 | $4.055 | $3.96 | 2,250 | |
| $4.045 | -0.005 | -0.1% | $4.005 | $4.05 | $4.005 | 3,050 | |
| $4.05 | -0.09 | -2.2% | $4.14 | $4.14 | $4.00 | 24,300 | |
| $4.14 | -0.01 | -0.2% | $3.95 | $4.145 | $3.95 | 11,400 | |
| $4.15 | -0.025 | -0.6% | $4.10 | $4.15 | $4.05 | 18,300 | |
| $4.175 | +0.01 | +0.2% | $4.15 | $4.20 | $4.10 | 62,900 | |
| $4.165 | -0.005 | -0.1% | $4.17 | $4.17 | $4.10 | 16,050 | |
| $4.17 | -0.01 | -0.2% | $4.18 | $4.195 | $4.17 | 12,750 | |
| $4.18 | -0.02 | -0.5% | $4.185 | $4.185 | $4.05 | 5,350 | |
| $4.20 | +0.07 | +1.7% | $4.08 | $4.20 | $4.05 | 26,000 | |
| $4.13 | 0.00 | 0.0% | $4.18 | $4.19 | $4.13 | 12,500 | |
| $4.13 | +0.205 | +5.2% | $3.95 | $4.195 | $3.95 | 4,700 | |
| $3.925 | -0.27 | -6.4% | $3.82 | $3.925 | $3.82 | 8,300 | |
| $4.195 | +0.075 | +1.8% | $4.10 | $4.20 | $4.035 | 24,150 | |
| $4.12 | +0.12 | +3.0% | $4.01 | $4.12 | $3.99 | 69,250 | |
| $4.00 | -0.075 | -1.8% | $3.80 | $4.02 | $3.80 | 54,400 | |
| $4.075 | -0.025 | -0.6% | $4.10 | $4.13 | $4.00 | 72,100 | |
| $4.10 | +0.06 | +1.5% | $3.805 | $4.20 | $3.805 | 80,900 | |
| $4.04 | +0.245 | +6.5% | $3.795 | $4.20 | $3.695 | 142,250 | |
| $3.795 | 0.00 | 0.0% | $3.67 | $3.795 | $3.67 | 8,450 | |
| $3.795 | -0.025 | -0.7% | $3.80 | $3.80 | $3.70 | 36,450 | |
| $3.82 | +0.05 | +1.3% | $3.77 | $3.865 | $3.77 | 22,250 | |
| $3.77 | -0.025 | -0.7% | $3.66 | $3.77 | $3.61 | 58,100 | |
| $3.795 | 0.00 | 0.0% | $3.795 | $3.795 | $3.795 | 0 | |
| $3.795 | +0.04 | +1.1% | $3.755 | $4.195 | $3.70 | 10,800 | |
| $3.755 | -0.195 | -4.9% | $3.95 | $3.95 | $3.65 | 27,250 | |
| $3.95 | +0.21 | +5.6% | $3.73 | $4.07 | $3.60 | 49,100 | |
| $3.74 | -0.005 | -0.1% | $3.74 | $3.74 | $3.74 | 0 | |
| $3.745 | 0.00 | 0.0% | $3.745 | $3.745 | $3.60 | 41,950 | |
| $3.745 | -0.055 | -1.4% | $3.75 | $3.75 | $3.65 | 16,000 | |
| $3.80 | -0.11 | -2.8% | $3.955 | $3.955 | $3.73 | 9,600 | |
| $3.91 | +0.21 | +5.7% | $3.78 | $3.91 | $3.68 | 14,900 | |
| $3.70 | -0.10 | -2.6% | $3.795 | $3.92 | $3.65 | 102,900 | |
| $3.80 | -0.05 | -1.3% | $3.85 | $3.85 | $3.715 | 11,400 | |
| $3.85 | +0.105 | +2.8% | $3.745 | $3.85 | $3.745 | 15,200 | |
| $3.745 | +0.065 | +1.8% | $3.68 | $3.83 | $3.68 | 40,200 | |
| $3.68 | -0.045 | -1.2% | $3.675 | $3.85 | $3.67 | 150,200 | |
| $3.725 | -0.065 | -1.7% | $3.55 | $3.815 | $3.55 | 50,050 | |
| $3.79 | -0.055 | -1.4% | $3.765 | $3.85 | $3.65 | 197,150 | |
| $3.845 | -0.035 | -0.9% | $3.75 | $3.855 | $3.70 | 13,550 | |
| $3.88 | -0.045 | -1.1% | $3.705 | $3.885 | $3.70 | 18,700 | |
| $3.925 | -0.015 | -0.4% | $3.71 | $3.925 | $3.71 | 9,500 | |
| $3.94 | -0.055 | -1.4% | $3.975 | $3.975 | $3.68 | 20,850 | |
| $3.995 | +0.14 | +3.6% | $3.66 | $4.005 | $3.63 | 41,100 | |
| $3.855 | +0.075 | +2.0% | $3.70 | $3.855 | $3.70 | 19,150 | |
| $3.78 | -0.075 | -1.9% | $3.85 | $3.855 | $3.66 | 30,950 | |
| $3.855 | -0.04 | -1.0% | $3.855 | $3.855 | $3.855 | 12,000 | |
| $3.895 | +0.095 | +2.5% | $3.69 | $3.895 | $3.685 | 16,350 | |
| $3.80 | -0.14 | -3.6% | $3.895 | $3.895 | $3.795 | 17,500 | |
| $3.94 | 0.00 | 0.0% | $3.94 | $3.94 | $3.94 | 100 | |
| $3.94 | +0.13 | +3.4% | $3.81 | $3.94 | $3.65 | 31,950 | |
| $3.81 | +0.04 | +1.1% | $3.81 | $3.81 | $3.78 | 28,050 | |
| $3.77 | -0.18 | -4.6% | $3.99 | $4.08 | $3.75 | 79,750 | |
| $3.95 | -0.05 | -1.2% | $3.875 | $4.035 | $3.85 | 37,750 | |
| $4.00 | -0.33 | -7.6% | $4.20 | $4.20 | $3.85 | 106,200 | |
| $4.33 | +0.58 | +15.5% | $3.90 | $4.70 | $3.82 | 165,900 | |
| $3.75 | -0.085 | -2.2% | $3.70 | $3.84 | $3.675 | 19,950 | |
| $3.835 | -0.03 | -0.8% | $3.865 | $3.87 | $3.735 | 4,650 | |
| $3.865 | -0.035 | -0.9% | $3.80 | $3.95 | $3.75 | 95,700 | |
| $3.90 | -0.10 | -2.5% | $4.03 | $4.03 | $3.75 | 158,400 |
- Ticker
- HKEX:2257
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Nov 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed $4.17 (-0.1%) on Nov 5, 2026
(1) Grant of share options and restricted share units and (2) conditional grant of restricted share units to a director
Oct 29, 2026
Closed $4.13 (0.0%) on Oct 30, 2026
Discloseable transaction supplemental announcement in relation to deemed disposal of equity interest in a subsidiary and grant of repurchase right
Oct 6, 2026
Closed $3.95 (+5.6%) on Oct 7, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Closed $3.95 (+5.6%) on Oct 7, 2026
Sirnaomics Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 4 in the last 12 months · 26 in all · newest Nov 4, 2026 · oldest 2023
- Decks
- 11 decks · latest 2024
Where Sirnaomics Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:2257 聖諾醫藥 · Home listing · This page | HKEX | Hong Kong | HKD |
| Frankfurt:V5Z | Frankfurt | Germany | EUR |
Valuation
Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- $542.4M HKD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Sirnaomics Ltd. · HKEX:2257 | US$51.13M | US$69.20M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Xilio Therapeutics, Inc. · NASDAQ:XLO | US$53.40M | −US$62.82M | n/a | −1.1× | n/a | 0.8× | −20.9% | 0.1× | 0.76 |
| Impact BioMedical, Inc. · AMEX:IBO | US$53.31M | US$53.29M | 33.0× | 1,402× | n/a | 5.3× | n/a | 0.0× | 0.06 |
| XBiotech Inc. · NASDAQ:XBIT | US$52.74M | −US$52.29M | n/a | n/a | n/a | 0.4× | n/a | 0.0× | 0.52 |
| Bonus Biogroup Ltd. · TASE:BONS | US$52.22M | US$54.52M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| iBio, Inc. · NASDAQ:IBIO | US$51.45M | −US$23.13M | n/a | −21.5× | n/a | 0.7× | n/a | 0.0× | 2.01 |
| Cinclus Pharma Holding AB · OMXSTO:CINPHA | US$51.21M | US$13.17M | n/a | 3.8× | n/a | 2.6× | −765.8% | 0.0× | n/a |
| Aldeyra Therapeutics, Inc. · NASDAQ:ALDX | US$50.70M | US$9.72M | n/a | n/a | n/a | 1.4× | n/a | 0.0× | 0.66 |
| Clene Inc. · NASDAQ:CLNN | US$50.69M | US$58.31M | n/a | 245× | n/a | n/a | n/a | n/a | 1.48 |
| Acrivon Therapeutics, Inc. · NASDAQ:ACRV | US$49.35M | −US$26.60M | n/a | n/a | n/a | 0.7× | n/a | 0.0× | 2.09 |
| Aptamer Sciences, Inc. · KRX:291650 | US$49.21M | US$34.46M | n/a | 8.6× | n/a | 1.6× | −215.8% | 0.0× | n/a |
| Median of the others | US$51.33M | US$11.45M | 33.0× | 6.2× | 1.1× | −215.8% | 0.0× | 0.76 |
Forecasts
Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.
- Price target
- 72.17 HKD · Analysts' mean
- EPS, year to Dec 2025
- -1.58 · 1 analyst
- Revenue, year to Dec 2025
- 70M · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| H. Fai Poon | Chairman of the Board, Executive Director and Chief Executive Officer |
| Poon Hung Fai | Chairman of the Board and Chief Executive Officer |
| Jake Tian | SR VP of R&D |
| Jerry Tse | SR VP of Coporate Managment |
Board
| Director | Role |
|---|---|
| H. Fai Poon | Chairman of the Board, Executive Director and Chief Executive Officer |
| Poon Hung Fai | Chairman of the Board and Chief Executive Officer |
| Lo Yee Hang | Independent non-executive Director |
| Wong Yu Shan Eugene | Independent non-executive Director |
| Yin Huijun | Non-executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q2 2025 | Aug 28, 2025 | −5.2% |
| Quarter to Mar 31, 2025 | Apr 25, 2025 | −1.6% |
| Q4 2024 | Mar 27, 2025 | −7.4% |
| Q4 2021 | Mar 31, 2022 | −1.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2023 Earnings Presentation | Earnings | 35 slides | 2024 |
| FY2023 Earnings Presentation | Earnings | 35 slides | 2024 |
| FY2023 Earnings Presentation | Earnings | 35 slides | 2024 |
| H1 2023 Earnings Presentation | Earnings | 44 slides | 2023 |
| Investor Presentation (2023) | Investor deck | 20 slides | 2023 |
| Technical Presentation (March 2022) | Technical | 31 slides | Mar 15, 2022 |
| FY2021 Earnings Presentation | Earnings | 25 slides | March 2022 |
| FY2021 Earnings Presentation | Earnings | 25 slides | March 2022 |
| H1 2022 Earnings Presentation | Earnings | 29 slides | 2022 |
| Investor Presentation (2022) | Investor deck | 14 slides | 2022 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (2022) | Investor deck | 14 slides | 2022 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Strategic investment of equity interest (registered capital) in subsidiary Target Company Closed: CNY 30M raised | Oct 6, 2026 | US$4.47M |
| Strategic investment of shares Announced: about HK$138M · HK$12 a share Buyers: Bloomage Biotech (approximately HKD 138 million; will hold approximately 9.44% of total issued share capital) Use of proceeds: Accelerate development and commercialization of aesthetics, longevity intervention and regenerative medicine programs | Sep 7, 2025 | US$17.7M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1.78M | 397.0K | 705.0K | 71.0K | 0 | 88.0K |
| Cost of revenue | 1.84M | 579.0K | 0 | 12.7M | |||
| Gross profit | -1.84M | 1.20M | 397.0K | 705.0K | -12.7M | 88.0K | |
| Research and development | 8.99M | 20.8M | 54.4M | 67.6M | 306.0M | 14.9M | 10.2M |
| Selling, general and administrative | 4.54M | 17.2M | 23.2M | 13.9M | 16.1M | 3.81M | 3.00M |
| Operating income | -15.4M | -36.8M | -77.1M | -91.1M | -441.4M | -20.1M | -15.0M |
| Depreciation and amortization | 1.84M | 5.56M | 6.16M | 3.93M | 1.63M | 1.04M | 828.2K |
| EBITDA | -13.5M | -31.2M | -71.0M | -87.2M | -439.8M | -19.0M | -14.2M |
| Interest expense | 813.2K | 1.05M | 986.0K | 798.0K | 2.63M | 243.0K | 229.0K |
| Income before tax | -14.6M | -50.2M | -85.0M | -97.4M | -1.68B | -46.4M | -17.1M |
| Income tax | -9.08M | -2.86M | -2.66M | -746.0K | |||
| Net income | -14.4M | -51.4M | -78.7M | -88.3M | -1.66B | -43.8M | -16.4M |
| Earnings per share, basic | -0.15 | -0.66 | -1.03 | -1.16 | -111.17 | -0.50 | -0.19 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13.5M | 11.8M | 23.9M | 105.2M | 212.0M | 103.1M | 9.95M |
| Short-term investments | 0 | 20.0M | 0 | 9.95M | |||
| Receivables | 818.0K | 639.0K | 598.0K | 1.95M | 80.0K | ||
| Current assets | 15.4M | 19.5M | 58.7M | 117.2M | 223.8M | 105.1M | 21.4M |
| Property, plant and equipment | 4.03M | 7.62M | 15.5M | 29.5M | 14.7M | 4.45M | 3.17M |
| Total assets | 20.6M | 28.3M | 75.8M | 163.9M | 240.6M | 110.2M | 24.8M |
| Accounts payable | 3.16M | 4.60M | 3.87M | 4.89M | 1.48M | 782.0K | 732.0K |
| Current liabilities | 38.2M | 37.2M | 13.0M | 14.2M | 16.2M | 94.1M | 2.80M |
| Long-term debt | 30.7M | 29.1M | 8.44M | 1.13M | 0 | ||
| Total debt | 9.31M | 8.06M | 8.85M | 10.8M | 7.04M | 91.9M | 1.99M |
| Total liabilities | 45.1M | 44.3M | 51.3M | 52.4M | 30.4M | 204.4M | 73.8M |
| Shareholders' equity | -9.91M | -1.68M | 40.2M | 122.0M | 211.6M | -94.4M | -51.8M |
| Shares outstanding | 94.5M | 77.5M | 76.1M | 76.0M | 14.9M | 88.1M | 88.1M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Cash from operations | -9.20M | -19.7M | -70.3M | -88.7M | -57.0M | -19.0M | -14.4M |
| Capital spending | -56.0K | -108.0K | -1.74M | -18.8M | -5.87M | -2.15M | -1.19M |
| Free cash flow | -9.25M | -19.8M | -72.0M | -107.5M | -62.8M | -21.1M | -15.6M |
| Cash from investing | 23.0K | 2.14M | -5.35M | -32.6M | -6.04M | 8.39M | 1.10M |
| Cash from financing | 10.9M | 5.82M | -5.61M | 15.9M | 171.0M | 100.4M | 11.5M |
| Share buybacks | 2.00K | -6.48M | -10.2M | 63.9M | -614.0K | -115.0K | |
| Change in cash | 1.75M | -12.1M | -81.3M | -106.8M | 108.9M | 93.2M | -1.74M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026 | Nov 4, 2026 | Monthly return | HKEX |
| (1) GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITS AND (2) CONDITIONAL GRANT OF RESTRICTED SHARE UNITS TO A DIRECTOR | Oct 29, 2026 | Other filings | HKEX |
| DISCLOSEABLE TRANSACTION SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DEEMED DISPOSAL OF EQUITY INTEREST IN A SUBSIDIARY AND GRANT OF REPURCHASE RIGHT | Oct 6, 2026 | Acquisition or disposal | HKEX |
| Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026 | Oct 6, 2026 | Monthly return | HKEX |
Cap table
Built by 6ix from Sirnaomics Ltd.’s releases · as of Oct 6, 2026
- Common shares
- 111,334,388
- Fully diluted
- 111,334,388
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 111,334,388 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 111,334,388 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| H. Fai Poon | Chairman of the Board, Executive Director and Chief Executive Officer · Since at least Nov 5, 2026 |
| Jake Tian | SR VP of R&D · Since at least Nov 5, 2026 |
| Jerry Tse | SR VP of Coporate Managment · Since at least Nov 5, 2026 |
| Lo Yee Hang | Independent non-executive Director · Since at least Nov 5, 2026 |
| Poon Hung Fai | Chairman of the Board and Chief Executive Officer · Since at least Nov 5, 2026 |
| Wong Yu Shan Eugene | Independent non-executive Director · Since at least Nov 5, 2026 |
| Yin Huijun | Non-executive Director · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Sirnaomics Ltd.